Trial and Evaluation Sample Clauses

Trial and Evaluation a b c d Where product requires, Respondents may be required to arrange a site visit during the evaluation stage to assist with introducing trial. Participating Health Services reserve the right to trial successful Respondents’ products on-site for reference prior to purchase. To limit the costs of any such trial, full integration to hospital systems is preferred but not required. Clinical trials will be minimum up to four (4) weeks or as mutually agreed between the successful Respondent and the Participating Health Service site. Suppliers must be capable of demonstrating their products within four (4) weeks of request. As part of the trial and evaluation, the Respondent must supply up to 4 weeks’ worth of product FOC, or a volume that is mutually agreedable with the Participating Health Service. Part C: General Requirements Clause Identifiers Text Part C General Requirements

Trial and Evaluation. In order to use the Services you must register a customer account representing the Customer, and the Customer’s organization, and enables the use of the Services in an associated active directory domain. The account registration details must always contain: 1. A customer name accurately reflecting the name of the Customer or Customer’s organization. 2. An associated email domain(s) registered to the Customer, the Customer’s organization, or an authorized agent or representative of the organization. 3. A valid email address where Specops can reach the contact responsible for the Customer’s account. If you are creating an account on behalf of a legal entity other than yourself, this represents and warrants that you are authorized to do so. Specops holds the account responsible for any actions taken in the Services by the users or administrators registered to the account. The terms of the Service may change, as required, in response to changes in the Services and technologies. Notifications of such changes will be sent to the registered administrator for each account. The Specops Services can be trialed for up to 10 active directory user accounts registered to the Customer’s account. During such conditions, Specops grants the Customer and the Customer’s organization a limited, nonexclusive, non-assignable and non-transferable subscription to access the Services and utilize the underlying software for the sole purpose of evaluating any of the supported Services. This trial version is offered free of charge, however, Specops reserves the right to modify, limit, suspend or terminate such access at any time, without notice to the Customer or the Customer’s organization. Should your account exceed 10 registered active directory user accounts, the Customer’s trial subscription will no longer be valid, and the Customer will be asked to contact Specops to obtain a paid subscription Service in accordance with this Agreement.

Trial and Evaluation. If you registered for a trial or evaluation use of the Services, you will have access to the appropriate parts of the Services for the specified period of the trial (“Trial Period”). You must decide to purchase a license to the Services within the Trial Period in order to retain access to any Content or data provided or created during the Trial and Evaluation Period. If you do not purchase a license to the Services by the end of the Trial and Evaluation Period, you will not be able to access or retrieve any of the data or Content you added to or created with the Services during the trial.

Trial and Evaluation. 6.1 The Trial Period during which Customer may Trial the Products and Services will begin on the Start Date (as set forth in Exhibit C). The Trial by Customer (i) will, subject to earlier termination of this MOU, continue for the duration of the Trial Period, and (ii) may only take place in the Trial Region. 6.2 Customer may use, test, and evaluate the Products and Services by sharing the Products, Services, and Documentation with authorised employees of the Customer. Customer will provide reports of problems, failures, or defects arising in connection with the Products, Services, and Documentation to Startup, and will implement a process reasonably acceptable to Startup for Customer and its auhtorised employees to provide feedback to Customer and Startup. Customer hereby grants Startup a worldwide, nonexclusive, perpetual, irrevocable, assignable, fully paid-up, royalty-free right and license to use any suggestion or idea for Startup’s products or services that Customer or its authorized employees communicates to Startup, without compensation, without any obligation to report on such use, and without any other restriction. 6.3 During the Trial Period, Customer will provide (i) Startup with reasonable access to the Products and Services, and (ii) access to any performance data held by Customer and relating to the Products and Services, in each case, to allow Startup to evaluate the performance of the Products and Services. 6.4 Customer shall not attempt to, nor permit, procure, enable, or request any other person or entity to (i) alter, adapt, copy, disassemble, decompile, reverse engineer, create derivative works of, or distribute externally the Products, Services, or Documentation, or any portion thereof, (ii) use the Products, Services, or Documentation to (a) create, market, or distribute any product or service that is competitive with the Products or Services, or (b) transfer, sell, lease, license, sublicense, distribute, disclose, divulge, or make available the Products, Services, or Documentation to, or permit use of or access to the Products, Services, or Documentation by, any person or entity (except as set forth in this MOU), or (iii) remove, alter, or obscure any intellectual property notice or other restrictive notice or legend contained or included in or on any of the Products, Services, or Documentation.

Trial and Evaluation